JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,620
+140 (1.04%)
Feb 20, 2026, 3:30 PM KST

JW Lifescience Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6,8637,51120,2223,9204,9232,592
Short-Term Investments
18,9322,1108,12624,953155.05-
Cash & Short-Term Investments
25,7959,62228,34828,8735,0782,592
Cash Growth
-53.71%-66.06%-1.82%468.59%95.88%-73.71%
Accounts Receivable
39,45043,04855,50553,42632,14134,716
Other Receivables
-16,784252.42346.01257.79161.45
Receivables
39,45059,83255,75753,77237,19836,578
Inventory
32,95535,44823,39922,06721,07716,786
Prepaid Expenses
-159.7824.78236.471,044505.8
Other Current Assets
1,454602.96305.5660.732.7934.08
Total Current Assets
99,655105,664107,834105,00864,43056,496
Property, Plant & Equipment
127,558132,051124,577131,555137,145135,423
Long-Term Investments
-558.5710,4194,3908,93413,097
Goodwill
30,70574,266950.99950.99950.99950.99
Other Intangible Assets
45,6943,2202,8703,1003,6713,916
Long-Term Deferred Tax Assets
--15.81---
Long-Term Deferred Charges
206.56248.81305.14484.8689.12893.45
Other Long-Term Assets
6,1969,3158,8657,4533,6463,626
Total Assets
310,014325,324255,836252,942219,467214,402
Accounts Payable
18,02719,61718,74015,11812,49610,714
Accrued Expenses
-1,6691,2711,156724.7655.62
Short-Term Debt
17,10027,70015,70036,68144,35032,000
Current Portion of Long-Term Debt
30,4288,11230,3533363362,817
Current Portion of Leases
214.15350.8244.91131.02159.77147.67
Current Income Taxes Payable
1,3318,5942,7393,6453,2796,200
Other Current Liabilities
15,40214,13625,41122,97622,55716,734
Total Current Liabilities
82,50180,17994,25980,04483,90269,268
Long-Term Debt
-31,89916830,0071,6101,512
Long-Term Leases
1,1071,17646.6840.4231.9160.65
Pension & Post-Retirement Benefits
4,1524,001----
Long-Term Deferred Tax Liabilities
7,2187,4061,8282,0112,2433,305
Other Long-Term Liabilities
179.37217.94141.95508.07187.87,762
Total Liabilities
95,158124,87996,443112,61087,97581,908
Common Stock
39,58639,58639,58639,58639,58639,586
Additional Paid-In Capital
28,33528,33528,33528,33528,33528,335
Retained Earnings
146,833132,42298,22079,16070,31964,572
Treasury Stock
-6,749-6,749-6,749-6,749-6,749-
Comprehensive Income & Other
6,8506,850000-
Shareholders' Equity
214,856200,445159,393140,332131,492132,494
Total Liabilities & Equity
310,014325,324255,836252,942219,467214,402
Total Debt
48,84969,23846,31367,19546,48836,537
Net Cash (Debt)
-23,054-59,616-17,965-38,322-41,410-33,945
Net Cash Per Share
-1488.83-3850.03-1160.20-2474.87-2657.82-2143.72
Filing Date Shares Outstanding
15.4815.4815.4815.4815.4815.83
Total Common Shares Outstanding
15.4815.4815.4815.4815.4815.83
Working Capital
17,15325,48513,57424,965-19,472-12,772
Book Value Per Share
13875.4812944.8210293.699062.748491.828367.39
Tangible Book Value
138,457122,959155,573136,281126,870127,627
Tangible Book Value Per Share
8941.657940.7310046.958801.128193.308060.01
Land
41,31341,31332,45932,45932,45932,459
Buildings
34,72836,98339,82041,64842,61844,529
Machinery
42,93749,26951,45056,83644,97646,086
Construction In Progress
7,2712,987758.47440.7316,90312,143
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.